ClinicalTrials.gov
public full text
Public Domain
Tamoxifen in Treating Women With Breast Cancer
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen may fight breast cancer by blocking the uptake of estrogen by the tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of at least 2 years of tamoxifen with that of 5 additional years of tamoxifen in treating women who have breast cancer that has been surgically removed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer#832002
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer#875900
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer#838386
- Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer#1030741
- Everolimus trIal for Advanced prememopausaL Breast Cancer Patients#913956
Record · ID 993486
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive